Skip to main content
Clinical Trials/NCT05227625
NCT05227625
Unknown
Not Applicable

Randomized Controlled Trial Assessing the Effectiveness of a Psychological Management Program for Body Dissatisfaction in Eating Disorders

University Hospital, Montpellier0 sites128 target enrollmentFebruary 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Eating Disorders
Sponsor
University Hospital, Montpellier
Enrollment
128
Primary Endpoint
Body dissatisfaction
Last Updated
4 years ago

Overview

Brief Summary

Eating disorders (ED) are a major public health problem for which current treatments are insufficiently effective. The transdiagnostic approach of eating disorders highlights body dissatisfaction (BD) as a major factor in the development and maintenance of the different types of eating disorders. Thus, we hypothesize that a group focused on the management of BDc would improve the prognosis of patients with eating disorders.

Detailed Description

Main and secondary objectives: To evaluate the effectiveness of a BD management group on the level of body dissatisfaction in patients suffering from an ED (BSQ-34 total score immediately after intervention). Secondary: To assess the effectiveness of a BD management group in 1) reducing the desire for thinness, 2) improving quality of life, 3) improving ED symptoms, 4) improvement in depressive symptomatology, 5) increase in cognitive flexibility and acceptance of unpleasant psychological events, 6) improvement in overall functioning. Methodology : Open randomized controlled trial with two intervention arms (management of BD versus relaxation). Main inclusion criteria: patients over 16 years of age suffering from an ED, presenting moderate to severe BD (BSQ-34≥111) and normal BMI Main endpoint: evolution of the level of BD (BSQ-34) immediately after the intervention. Secondary judgment criteria: change in the level of BD (BSQ-34) at 1 and 3 months post-intervention \& change in eating symptomatology (EDI, EDE-Q), quality of life (EDQOL), level of depression (MADRS), cognitive flexibility ( AAQ), functioning (WSAS) immediately post-intervention, at 1 and 3 months post-intervention. Procedure: The participation of each patient includes 4 evaluation visits: inclusion, just after the end of the intervention, at 1 and 3 months after the end of the intervention Benefits / prospects: We hope that patients who have integrated the interventional group will show a significant improvement in their BD, their functioning and the overall prognosis of the disorder. Positive results would permit to consider a larger multicenter study evaluating the long-term effect of the group on different dimensions of the ED. Finally, it would then be possible to offer standardized care that can be generalized to other centers.

Registry
clinicaltrials.gov
Start Date
February 2022
End Date
August 2024
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ED according to DSM 5 criteria (all types of ED can be included: anorexia, bulimia, binge eating disorder, atypical ED, etc.)
  • BMI between 18.5 kg/m2 and 24.9 kg/m2).
  • woman over the age of 16
  • moderate to severe body dissatisfaction (total BSQ score greater than or equal to 111)

Exclusion Criteria

  • current severe psychiatric pathology other than the TCA (severe depression, schizophrenia, etc.) which may alter the ability to follow the group in the opinion of the investigator
  • Patient under legal protection measure (guardianship, curatorship, safeguard of justice, authorization family or future protection mandate activated
  • Pregnant or breastfeeding women according
  • Patient not affiliated to a social security scheme, or beneficiary of such a scheme
  • Patient unable to understand the nature, purpose and methodology of the study
  • Patient who did not sign the informed consent
  • Patient whose legal guardian has not given consent to inclusion

Outcomes

Primary Outcomes

Body dissatisfaction

Time Frame: immediate post intervention

Assessment of body dissatisfaction using Body shape questionnaire (BSQ-34) 34-item self-administered questionnaire assessing body dissatisfaction across four dimensions: avoidance and social shame of body exposure, body dissatisfaction with lower parts of the body, use of laxatives and vomiting to reduce body dissatisfaction, cognitions and maladaptive behaviors to control weight. The total score ranges from 0 to 204. A score below 80 indicates no excessive body dissatisfaction, a score between 80 and 100 indicates mild body dissatisfaction, between 111 and 140 moderate body dissatisfaction and a score above 140 indicates severe body dissatisfaction

Secondary Outcomes

  • Body dissatisfaction(3 months post intervention)
  • Eating disorder symptomatology(3 months post intervention)
  • cognitive flexibility(3 months post intervention)
  • Global functioning(3 months post intervention)
  • eating behavior(3 months post intervention)
  • Quality of life level(3 months post intervention)
  • depressive symptomatology(3 months post intervention)
  • mindfulness skills(3 months post intervention)

Similar Trials